Kovitz Investment Group Partners LLC lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 247.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,451 shares of the medical equipment provider's stock after purchasing an additional 5,308 shares during the period. Kovitz Investment Group Partners LLC's holdings in Intuitive Surgical were worth $3,660,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also recently modified their holdings of the business. Dynamic Advisor Solutions LLC lifted its stake in Intuitive Surgical by 2.5% during the second quarter. Dynamic Advisor Solutions LLC now owns 10,245 shares of the medical equipment provider's stock worth $4,557,000 after purchasing an additional 252 shares in the last quarter. LVW Advisors LLC lifted its stake in Intuitive Surgical by 9.9% during the second quarter. LVW Advisors LLC now owns 1,320 shares of the medical equipment provider's stock worth $587,000 after purchasing an additional 119 shares in the last quarter. Sequoia Financial Advisors LLC lifted its stake in Intuitive Surgical by 6.0% during the second quarter. Sequoia Financial Advisors LLC now owns 7,310 shares of the medical equipment provider's stock worth $3,252,000 after purchasing an additional 417 shares in the last quarter. Cooper Financial Group lifted its stake in Intuitive Surgical by 9.2% during the second quarter. Cooper Financial Group now owns 629 shares of the medical equipment provider's stock worth $280,000 after purchasing an additional 53 shares in the last quarter. Finally, M&G Plc lifted its stake in Intuitive Surgical by 53.5% during the second quarter. M&G Plc now owns 5,069 shares of the medical equipment provider's stock worth $2,256,000 after purchasing an additional 1,766 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.
Analysts Set New Price Targets
Several equities analysts recently commented on the company. JPMorgan Chase & Co. increased their target price on Intuitive Surgical from $495.00 to $575.00 and gave the company an "overweight" rating in a report on Friday, October 11th. Raymond James raised their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an "outperform" rating in a research report on Monday, October 14th. Leerink Partners increased their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Evercore ISI restated a "cautious" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Tuesday, November 19th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $541.33.
Read Our Latest Analysis on ISRG
Insider Activity at Intuitive Surgical
In other Intuitive Surgical news, EVP Robert Desantis sold 238 shares of the firm's stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $477.50, for a total transaction of $113,645.00. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,629,115. This trade represents a 4.14 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Mark Brosius sold 2,115 shares of the firm's stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $491.91, for a total value of $1,040,389.65. Following the transaction, the insider now owns 295 shares in the company, valued at approximately $145,113.45. This trade represents a 87.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 50,723 shares of company stock valued at $26,241,747. 0.80% of the stock is owned by company insiders.
Intuitive Surgical Stock Performance
Shares of ISRG stock traded down $11.55 during trading hours on Monday, hitting $538.86. 1,428,757 shares of the company were exchanged, compared to its average volume of 1,445,554. The firm has a market cap of $191.93 billion, a P/E ratio of 86.63, a P/E/G ratio of 5.41 and a beta of 1.38. Intuitive Surgical, Inc. has a fifty-two week low of $309.80 and a fifty-two week high of $556.23. The company has a 50 day simple moving average of $517.16 and a two-hundred day simple moving average of $475.65.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.
Intuitive Surgical Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.